nifedipine has been researched along with physostigmine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Furukawa, T; Katsuragi, T; Ogawa, S; Shirakabe, K; Soejima, O | 1 |
| Maggi, CA | 1 |
| Kontani, H; Nakagawa, M; Sakai, T; Takeno, S | 1 |
| Iravani, MM; Luheshi, GN; Zar, MA | 1 |
| Bourson, A; Moser, PC | 1 |
| Battaglia, M; Pavone, F; Sansone, M | 1 |
| Nath, C; Sinha, JN; Srivastava, SK | 1 |
| Beleslin, D; Jankovic, S; Mircic, G | 1 |
| Ascione, V; Aviello, G; Borrelli, F; Capasso, F; Capasso, R; Posadas, I | 1 |
1 review(s) available for nifedipine and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for nifedipine and physostigmine
| Article | Year |
|---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Involvement of dihydropyridine-sensitive Ca2+ channels in adenosine-evoked inhibition of acetylcholine release from guinea pig ileal preparation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Acetylcholine; Adenosine; Animals; Atropine; Bethanechol; Bethanechol Compounds; Calcium Channels; Chromatography, High Pressure Liquid; Dihydropyridines; Electric Stimulation; Guinea Pigs; Ileum; Male; Muscle, Smooth; Nifedipine; Physostigmine; Tetrodotoxin; Theophylline | 1990 |
Omega conotoxin and prejunctional modulation of the biphasic response of the rat isolated urinary bladder to single pulse electrical field stimulation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine Triphosphate; Animals; Atropine; Calcium Channel Blockers; Calcium Channels; Clonidine; Drug Interactions; Drug Synergism; Electric Stimulation; Male; Muscle Contraction; Muscle, Smooth; Neurokinin A; Nifedipine; omega-Conotoxins; Peptides, Cyclic; Physostigmine; Rats; Rats, Inbred Strains; Urinary Bladder | 1991 |
Evaluation of drugs for treatment of urinary bladder dysfunction in conscious rats with intact pelvic nerve and after resection of the left pelvic nerve.
Topics: Animals; Atropine; Butylamines; Decerebrate State; Drug Evaluation; Male; Mandelic Acids; Nifedipine; Parasympatholytics; Physostigmine; Rats; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Diseases | 1990 |
Effect of nifedipine on the contractile responses of the isolated rat bladder.
Topics: Acetylcholine; Animals; Atropine; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Neural Conduction; Nifedipine; Physostigmine; Rats; Tetrodotoxin; Urinary Bladder | 1990 |
The effect of pre- and postoperative procedures on physostigmine- and apomorphine-induced yawning in rats.
Topics: Animals; Apomorphine; Desipramine; Drug Interactions; Male; Medial Forebrain Bundle; Nifedipine; Pentobarbital; Physostigmine; Rats; Rats, Inbred Strains; Stress, Physiological; Surgical Procedures, Operative; Yawning | 1989 |
Attenuation of cholinergic analgesia by nifedipine.
Topics: Analgesics; Animals; Hot Temperature; Hydralazine; Male; Mice; Mice, Inbred Strains; Nifedipine; Oxotremorine; Pain Measurement; Parasympathomimetics; Physostigmine; Reaction Time | 1993 |
Evidence for antiaggressive property of some calcium channel blockers.
Topics: Aggression; Amphetamine; Animals; Calcium Channel Blockers; Central Nervous System Stimulants; Depression, Chemical; Diltiazem; Electroshock; Male; Mice; Nifedipine; Parasympathomimetics; Physostigmine; Verapamil | 1997 |
Differences in the effects of vasopressin and oxytocin on feline gastric corpus motility: selective action of vasopressin on longitudinal muscle.
Topics: Animals; Atropine; Cats; Female; In Vitro Techniques; Male; Muscle Contraction; Nifedipine; Oxytocin; Physostigmine; Pregnancy; Stomach; Vasopressins | 1998 |
Effect of caffeic acid phenethyl ester on gastric acid secretion in vitro.
Topics: 1-Methyl-3-isobutylxanthine; Acetylcholinesterase; Animals; Caffeic Acids; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Gastrointestinal Agents; Histamine; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Muscarine; Nifedipine; Pentagastrin; Phenylethyl Alcohol; Physostigmine; Potassium; Stomach | 2005 |